Prospectus

Tempest Therapeutics, Inc. Filed 2026-10-02 Acc 0001213900-26-106362

Documents 1

2026-10-02 4 Options or other derivatives
2026-10-02 3 Initial Statement of Ownership
2026-10-02 424B3 Prospectus
2026-10-01 EFFECT Notice of Effectiveness
2026-09-28 8-K Material agreement · Executive or director change · Regulation FD disclosure
2026-09-25 S-3 Registration Statement
2026-09-01 424B3 Prospectus

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

Loading ea0307277-424b3_tempest.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…